Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial

[1]  K. Ker,et al.  Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. , 2011, The Cochrane database of systematic reviews.

[2]  Alan D. Lopez,et al.  Maternal mortality for 181 countries, 1980–2008: a systematic analysis of progress towards Millennium Development Goal 5 , 2010, The Lancet.

[3]  D. Elbourne,et al.  The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial , 2010, Trials.

[4]  Fiona Lecky,et al.  Intracranial bleeding in patients with traumatic brain injury: A prognostic study , 2009, BMC emergency medicine.

[5]  I. Roberts,et al.  Bmc Pregnancy and Childbirth Open Access Anti-fibrinolytic Agents in Post Partum Haemorrhage: a Systematic Review , 2022 .

[6]  M. Kenward,et al.  Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls , 2009, BMJ : British Medical Journal.

[7]  David A Spiegel,et al.  Injuries: the neglected burden in developing countries. , 2009, Bulletin of the World Health Organization.

[8]  P. Edwards,et al.  BMC Medical Research Methodology BioMed Central , 2008 .

[9]  M. Cohen,et al.  Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. , 2008, The Journal of trauma.

[10]  Ewout Steyerberg,et al.  Predicting outcome after traumatic brain injury: practical prognostic models based on large cohort of international patients , 2008, BMJ : British Medical Journal.

[11]  Salim Yusuf,et al.  Specific barriers to the conduct of randomized trials , 2008, Clinical trials.

[12]  Juan Lu,et al.  Prognostic value of computerized tomography scan characteristics in traumatic brain injury: results from the IMPACT study. , 2007, Journal of neurotrauma.

[13]  Rolf Lefering,et al.  Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. , 2006, The Journal of trauma.

[14]  I Roberts,et al.  Antifibrinolytic drugs for acute traumatic injury. , 2004, The Cochrane database of systematic reviews.

[15]  J. Lawson,et al.  Challenges for providing effective hemostasis in surgery and trauma. , 2004, Seminars in hematology.

[16]  Lance J. Oyen,et al.  Plasma Tranexamic Acid Concentrations During Cardiopulmonary Bypass , 2001, Anesthesia and analgesia.

[17]  J. Weckström,et al.  Tranexamic Acid Reduces Blood Loss in Total Hip Replacement Surgery , 2000, Anesthesia and analgesia.

[18]  R. Maier,et al.  Trauma mortality patterns in three nations at different economic levels: implications for global trauma system development. , 1997, The Journal of trauma.

[19]  Y. Okada,et al.  Enzyme-Controlling Medicines: Introduction , 1997, Seminars in thrombosis and hemostasis.

[20]  A Busuttil,et al.  The time of death after trauma , 1995, BMJ.

[21]  D. V. Van Riper,et al.  The Dose‐Response Relationship of Tranexamic Acid , 1995, Anesthesiology.

[22]  A. Rodgers,et al.  Systematic Underestimation of Treatment Effects as a Result of Diagnostic Test Inaccuracy: Implications for the Interpretation and Design of Thromboprophylaxis Trials , 1995, Thrombosis and Haemostasis.

[23]  A. Sauaia,et al.  Epidemiology of trauma deaths: a reassessment. , 1993, The Journal of trauma.